离散事件模拟模型用于COPD管理的应用:系统性审查
Liu Shuai1, Chunni Zhou1, Jinyi Zhou2
1School of Public Health, Southeast University, Nanjing, People's Republic of China.
概括
离散事件模拟 (DES) 模型越来越多地用于管理慢性阻塞性肺病 (COPD). 本综述综合了COPD中DES应用的证据,确定了研究缺口和优化干预措施的未来方向.
科学领域:
- 卫生经济学 卫生经济学
- 医疗保健服务研究 医疗服务研究
- 计算机建模 计算建模
背景情况:
- 慢性阻塞性肺病 (COPD) 的管理提出了复杂的挑战.
- 离散事件模拟 (DES) 提供了一个强大的工具来建模和评估COPD干预措施.
- 需要对当前在COPD中的DES应用进行全面评估.
研究的目的:
- 在慢性阻塞性肺病 (COPD) 的管理中系统地审查和综合离散事件模拟 (DES) 模型的应用.
- 评估现有研究的质量,确定知识差距,并为未来在COPD护理中的DES应用提供建议.
主要方法:
- 在六个数据库 (PubMed,科学网,Embase,Cochrane,Econlit,CNKI) 进行系统的文献搜索,截至2024年8月22日.
- 使用CHEERS 2022检查清单或ISPOR实践指南进行质量评估.
- 纳入研究的分类基于建模重点:药理疗法,病例检测和医疗保健服务干预.
主要成果:
- 九项研究符合纳入标准,所有研究都侧重于高收入国家中COPD管理中DES的健康经济评估.
- 研究涵盖了药理治疗 (n=3),病例检测策略 (n=3) 和医疗服务干预措施 (n=3) 的成本效益.
- 所有研究都报告了模型验证,但只有两个包括子组分析.
结论:
- 离散事件模拟 (DES) 是COPD管理中的健康经济评估的一个有价值的工具.
- 建议进行进一步的研究,以解决发现的差距,特别是在子组分析和各种医疗保健环境中.
- 结果可以为未来的研究重点和资源分配提供信息,以加强COPD干预措施.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170


